Accellacare of Hickory — Hickory, North Carolina

Accellacare of Hickory is a clinical research site located in Hickory, North Carolina, United States 28601.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Accellacare of Hickory has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Influenza, Obese, Obesity.

Sponsors: Biomedical Advanced Research and Development Authority, Hanmi Pharmaceutical Company Limited, Amgen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hickory

Browse all research sites in North Carolina · View every site in Hickory

• Catawba Memorial Hospital
• PMG Research of Hickory
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Clinical Trials of America
• Graystone Eye
• Novartis Investigative Site
• Local Institution
• Unifour Medical Research Associates
• Accellacare Hickory
• Clinical Research Site

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare of Hickory?

Accellacare of Hickory has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare of Hickory conducted?

Accellacare of Hickory has 6 clinical trials on record, with 4 currently active. Their work covers Influenza, Obese, Obesity.

Is Accellacare of Hickory accredited by Crixeo Clinical Trials?

Accellacare of Hickory has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accellacare of Hickory?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.